Supplemental material
Report
Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations
Joel Heislera Department of Antibody Engineering, Genentech, Inc, South San Francisco, CA, USA
https://orcid.org/0000-0002-2703-3035View further author information
https://orcid.org/0000-0002-2703-3035View further author information, , Saeed Izadib Department of Pharmaceutical Development, Genentech, Inc, South San Francisco, CA, USAhttps://orcid.org/0000-0003-4206-8559View further author information
https://orcid.org/0000-0003-4206-8559View further author information, & Paul J. Cartera Department of Antibody Engineering, Genentech, Inc, South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0001-7854-062XView further author information
https://orcid.org/0000-0001-7854-062XView further author information
